U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 10-16, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 10-16, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 10/13/2021
Location: Virtual
Subject: National Academies Forum on Drug Discovery, Development and Translation: Establishing A Clinical Trials Network
FDA Participant/Group: LEONARD SACKS; KEVIN BUGIN; DAYLE CRISTINZIO;
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Event Date: 10/13/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Event Date: 10/13/2021
Location: Virtual
Subject: Sodium Reduction Final Guidance Stakeholder Call
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Healthcare stakeholder groups, public health organizations, and other invited guests

Event Date: 10/15/2021
Location: Virtual
Subject: National Advocacy Week: Building Public Health Infrastructure and Physician Advocacy
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Medical Student Section of the American Medical Association and other invited participants

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 10/14/2021
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 10/13/2021
Location: Washington, D.C.
Subject: Returning Pharmaceutical Manufacturing to the United States Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: William Kirton (Winston & Strawn);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/13/2021
Location: Virtual
Subject: Duke Margolis Center for Health Policy Workshop - Reconsidering Mandatory Opioid Prescriber Education; Speaker: Opening Remarks
FDA Participant/Group: MICHIE HUNT;
Non FDA Participant/Group: Industry, academia, government, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/14/2021
Location: Virtual
Subject: Vaccines and Related Biological Products Advisory Committee; Introduction of the Topic
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Attendees of the Vaccines and Related Biological Products Advisory Committee

Event Date: 10/15/2021
Location: Virtual
Subject: Vaccines and Related Biological Products Advisory Committee; Introduction of the Topic
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Attendees of the Vaccines and Related Biological Products Advisory Committee

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 10/14/2021
Location: Virtual
Subject: Transparency of Artificial Intelligence/Machine Learning (AI/ML) Enabled Medical Devices Workshop; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Digital health stakeholders

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 10/15/2021
Location: Virtual
Subject: Interview with Alliance for a Stronger FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, goverment, and media

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top